Cargando…

An HNSCC syngeneic mouse model for tumor immunology research and preclinical evaluation

The lack of reliable animal models to assess the safety and efficacy of drugs and to explore the underlying molecular mechanisms is one of the most severe impediments in head and neck squamous cell carcinoma (HNSCC) tumor immunology research. The majority of xenograft tumor models established using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, You, Tian, Guocai, Li, Jiang, Zhang, Zhiyuan, Xu, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447356/ https://www.ncbi.nlm.nih.gov/pubmed/32700748 http://dx.doi.org/10.3892/ijmm.2020.4680

Ejemplares similares

SYT7 acts as an oncogene and a potential therapeutic target and was regulated by ΔNp63α in HNSCC
por: Fu, You, et al.
Publicado: (2021)

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
por: Tao, Wenjie, et al.
Publicado: (2021)

Fewer tumour-specific PD-1(+)CD8(+) TILs in high-risk “Infiltrating” HPV(−) HNSCC
por: Xu, Ke, et al.
Publicado: (2020)

TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
por: Zeng, Zexian, et al.
Publicado: (2021)

Analysis and Augmentation of the Immunologic Bystander Effects of CAR T Cell Therapy in a Syngeneic Mouse Cancer Model
por: Klampatsa, Astero, et al.
Publicado: (2020)

Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
por: Khalsa, Jasneet Kaur, et al.
Publicado: (2020)

Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
por: Adewunmi, Oluwatoyosi, et al.
Publicado: (2023)

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
por: Piranlioglu, Raziye, et al.
Publicado: (2019)

Anti-tumor effect of aquaporin 3 monoclonal antibody on syngeneic mouse tumor model
por: Tanaka, Manami, et al.
Publicado: (2022)

A murine preclinical syngeneic transplantation model for breast cancer precision medicine
por: Federico, Lorenzo, et al.
Publicado: (2017)

Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors
por: Zhong, Wenyan, et al.
Publicado: (2020)

Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models
por: Gutierrez, Wade R., et al.
Publicado: (2021)

Machine learning on syngeneic mouse tumor profiles to model clinical immunotherapy response
por: Zeng, Zexian, et al.
Publicado: (2022)

DNA based neoepitope vaccination induces tumor control in syngeneic mouse models
por: Viborg, Nadia, et al.
Publicado: (2023)

Sex Reporting in Preclinical Microbiological and Immunological Research
por: Potluri, Tanvi, et al.
Publicado: (2017)

Mechanisms of syngeneic tumor rejection. Susceptibility of host- selected progressor variants to various immunological effector cells
Publicado: (1982)

Re-evaluation of mouse models of endometriosis for pathological and immunological research
por: He, Ying, et al.
Publicado: (2022)

Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance
por: O’Keefe, Rachel A., et al.
Publicado: (2020)

Development of a syngeneic mouse model of epithelial ovarian cancer
por: Quinn, Bridget A, et al.
Publicado: (2010)

Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model
por: Lin, Kai-Ti, et al.
Publicado: (2017)

The impact of tumor immunogenicity on cancer pain phenotype using syngeneic oral cancer mouse models
por: Horan, Nicole L., et al.
Publicado: (2022)

Tumor-localized catalases can fail to alter tumor growth and transcriptional profiles in subcutaneous syngeneic mouse tumor models
por: Sheen, Allison, et al.
Publicado: (2023)

Longitudinal evaluation of the biodistribution and cellular internalization of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models
por: Sandker, Gerwin Gerhard Wemke, et al.
Publicado: (2023)

Immunological responsiveness of neonatal A/J mice to isotypic determinants of syngeneic IgE
Publicado: (1988)

THE CYTOTOXIC EFFECT OF MOUSE MACROPHAGES ON SYNGENEIC AND ALLOGENEIC ERYTHROCYTES
por: Melsom, H., et al.
Publicado: (1973)

Searching for Promoters to Drive Stable and Long-Term Transgene Expression in Fibroblasts for Syngeneic Mouse Tumor Models
por: Antonova, Dina V., et al.
Publicado: (2020)

Infiltration of Immune Competent Cells into Primary Tumors and Their Surrounding Connective Tissues in Xenograft and Syngeneic Mouse Models
por: Metzen, Marlon, et al.
Publicado: (2021)

Tumor Purity in Preclinical Mouse Tumor Models
por: Qian, Wubin, et al.
Publicado: (2022)

Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response
por: Sato, Yosuke, et al.
Publicado: (2021)

Ly phenotype of cytotoxic T cells for syngeneic tumor
Publicado: (1976)

Quantitative Imaging of Hypoxic CAIX-Positive Tumor Areas with Low Immune Cell Infiltration in Syngeneic Mouse Tumor Models
por: Boreel, Daan F., et al.
Publicado: (2023)

Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through Specific Protein Oxidation and Autophagy in a Syngeneic Breast Tumor Preclinical Model
por: Dickey, Jennifer S., et al.
Publicado: (2013)

A biomimetic nanoplatform for customized photothermal therapy of HNSCC evaluated on patient-derived xenograft models
por: Wu, Qi, et al.
Publicado: (2023)

A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
por: Huang, Tuxiong, et al.
Publicado: (2020)

Enhancement of syngeneic murine tumour transplantability by whole body irradiation--a non-immunological phenomenon.
por: Peters, L. J.
Publicado: (1975)

QUANTITATIVE STUDIES OF THE ADOPTIVE IMMUNOLOGICAL MEMORY IN MICE : I. AN AGE-DEPENDENT BARRIER TO SYNGENEIC TRANSPLANTATION
por: Celada, Franco
Publicado: (1966)

Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC
por: Li, Ce, et al.
Publicado: (2023)

Characterization of immune cell populations in syngeneic murine tumor models
por: Snipstad, Sofie, et al.
Publicado: (2023)

Mouse models of breast cancer in preclinical research
por: Park, Mi Kyung, et al.
Publicado: (2018)

Dirofilariasis mouse models for heartworm preclinical research
por: Marriott, A. E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_badgh1o3hbvht9o0j113nflqqc